These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35445091)

  • 1. Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention After Risk Stratification With the CHA
    Na K; Qiu M; Ma S; Li Y; Li J; Liu R; Zhang J; Han Y
    Front Cardiovasc Med; 2022; 9():808571. PubMed ID: 35445091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
    Zhang D; Li P; Qiu M; Liang Z; He J; Li Y; Han Y
    Atherosclerosis; 2024 Mar; 390():117395. PubMed ID: 38114408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention].
    Na K; Li MY; Qiu MH; Li J; Liu R; Li Y; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Nov; 49(11):1117-1123. PubMed ID: 34775722
    [No Abstract]   [Full Text] [Related]  

  • 4. Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Li Y; Li Y; Qiu M; Xue Y; Xu K; Han Y
    Res Pract Thromb Haemost; 2024 Mar; 8(3):102375. PubMed ID: 38623472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries.
    Peyracchia M; Saglietto A; Biolè C; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Liebetrau C; Manzano-Fernández S; Boccuzzi G; Henriques JPS; Wilton SB; Velicki L; Xanthopoulou I; Correia L; Rognoni A; Fabrizio U; Nuñez-Gil I; Montabone A; Taha S; Fujii T; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Kawaji T; Blanco PF; Garay A; Quadri G; Queija BC; Huczek Z; Paz RC; González-Juanatey JR; Fernández MC; Nie SP; D'Amico M; Pousa IM; Kawashiri MA; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Lopez-Cuenca A; Cequier A; Alexopoulos D; Iñiguez-Romo A; Grossomarra W; Usmiani T; Rinaldi M; D'Ascenzo F
    Am J Cardiovasc Drugs; 2020 Jun; 20(3):259-269. PubMed ID: 31586336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome.
    Li D; Sun Y; Ye X; Li L; Chen Y; Wang D
    Adv Ther; 2022 Jan; 39(1):754-766. PubMed ID: 34904209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Li Y; Li J; Qiu M; Ma S; Na K; Li X; Qi Z; Chen S; Li Y; Han Y
    Catheter Cardiovasc Interv; 2022 May; 99 Suppl 1():1395-1402. PubMed ID: 35032148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM
    JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Predictive Value of CHA
    Borovac JA; Kwok CS; Mohamed MO; Fischman DL; Savage M; Alraies C; Kalra A; Nolan J; Zaman A; Ahmed J; Bagur R; Mamas MA
    Cardiovasc Revasc Med; 2021 Aug; 29():61-68. PubMed ID: 32828675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    Asher E; Abu-Much A; Bragazzi NL; Younis A; Younis A; Masalha E; Goldkorn R; Mazin I; Fefer P; Barbash IM; Segev A; Beigel R; Matetzky S
    J Cardiol; 2021 Apr; 77(4):375-379. PubMed ID: 33067076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Wang HY; Li Y; Xu XM; Li J; Han YL
    Chin Med J (Engl); 2018 Sep; 131(17):2017-2024. PubMed ID: 30127210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R
    Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score Stratification-Based Analysis in a Large-Scale, Real-World Study From China.
    Qiu M; Na K; Qi Z; Zhou H; Li P; Xu K; Wang B; Liu H; Li J; Li Y; Han Y
    Mayo Clin Proc; 2023 Jul; 98(7):1021-1032. PubMed ID: 37419570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Li X; Qiu M; Na K; Li Y; Ma S; Qi Z; Li J; Li Y; Han Y
    Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():1032-1039. PubMed ID: 33650763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of genotype-guided selection of P2Y
    Wu Y; Yu D; Zhang L; Wu Y; Shu B; Ma L; Shi T
    Eur J Clin Pharmacol; 2023 Sep; 79(9):1249-1259. PubMed ID: 37449992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials.
    Abdelazeem B; Shehata J; Abbas KS; El-Shahat NA; Baral N; Adhikari G; Khan H; Hassan M
    Am J Cardiovasc Drugs; 2022 May; 22(3):287-298. PubMed ID: 34651261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
    Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the CHA
    Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
    Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.